“american-society-of-hematology” Archives

in
Entry Author Date Location
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO 12/07/18 National
Viracta, Neurelis & More: The Latest in San Diego Biotech 12/05/18 San Diego
BCMA Day: At ASH ‘18, Cell Therapies For Myeloma Take Center Stage 12/04/18 National
ASH 2018: Three Up, Two Down as Big Blood Disease Meeting Rolls On 12/03/18 National
Bio Roundup: CRISPR Babies, Blood Diseases, Big Cancer Nod & More 11/30/18 National
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
MEI Pharma Inks Cancer Drug Deal with Japan’s Kyowa Hakko Kirin 11/05/18 San Diego
Bio Roundup: Depression Drug Dashed, Peek at ASH, CRISPR Worry & More 11/02/18 National
In Week of Hemophilia News, Alnylam Drug Cleared to Move Forward 12/15/17 Boston
Bio Roundup: Tax Cuts, a Funding Rush, Hemophilia Questions & More 12/15/17 National
ASH Sneak Peeks: Novartis, Juno Update CAR-T Lymphoma Competition 11/01/17 National
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
At Late-Night ASH Talk, Juno Execs Look Beyond Stalled “Rocket” Trial 12/06/16 Seattle
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Fresh Off ASH Data, Spark Teams With Selecta to Boost Gene Therapies 12/05/16 Boston
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
New Data Show Power, Limits of Bluebird’s Gene Therapy For Blood Diseases 11/03/16 Boston
Epizyme Touts Early Data From Key Trial Of Blood Cancer Drug 06/19/16 Boston
East Coast Biotech Roundup: ASH, Kallyope, SQZ, Kyras & More 12/11/15 Boston
At Hematological Meeting, More Than Just Biotech Data Runs Blood Red 12/08/15 National
New Bluebird Data Hint at Gene Therapy’s Limits For Some Patients 11/05/15 Boston
Move West, Raise Cash: ProNAi’s Hot Streak Now Includes $138M IPO 07/16/15 Detroit Ann Arbor
After Celgene Deal, Juno Revs Armored CAR For Ovarian Cancer Trial 07/10/15 Seattle
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Bluebird 4 For 4 As Gene Therapy Helps More Blood Disease Patients 12/08/14 Boston
Immunotherapy Confidence (And Audience) Abundant At ASH T-Cell Talk 12/08/14 National
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
Page 1 of 3 next page »